Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04860960
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-04
First Post:
2021-04-15
Brief Title:
Phase 3 Study to Evaluate Intravenous TrappsolR CycloTM in Pediatric and Adult Patients With Niemann-Pick Disease Type C1
Sponsor:
Cyclo Therapeutics Inc
Organization:
Cyclo Therapeutics Inc
Organization Data
Organization:
Cyclo Therapeutics Inc
Class:
INDUSTRY
Study ID:
CTD-TCNPC-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cyclo Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None